Max Healthcare Institute Ltd. has broken out of a descending trendline resistance on daily charts, signaling a potential shift in momentum. Experts suggest long-term investors with a high-risk profile consider buying the stock, targeting Rs 1,400 in the next 12 months, with a stop loss at Rs 850.